0 items USD 0.00Search
- Did you mean
- bruton’s tyrolit kinase
Your search for "Bruton's tyrosine kinase" gave back 33799 results.
Nilotinib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). Publisher' newest research report, the “Nilotinib Industry...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Combining next-generation gene sequencing technology with a bioinformatics platform, mainly targeted at genetically defined patients. The global...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Icotinib (trade name Conmana) is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK)...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Anlotinib is a new, orally administered tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (VEGFR), fibroblast growth...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-...
Catalog:
LPI
March 2023
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Hematological Malignancy Drugs market will undergo major...
Catalog:
Arsta
June 2022
Price: USD 3,360.00
Icotinib (trade name Conmana) is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Nilotinib market size was valued at US$ 1881.2 million in 2023. With growing demand in downstream market, the Nilotinib is forecast to a...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Cabozantinib, sold under the brand-name Cabometyx and Cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The fibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR) is a tyrosine kinase signaling pathway that has a fundamental role in many...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The most effective targeted drug introduced for HCC has been sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The most effective targeted drug introduced for HCC has been sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic...
Catalog:
LPI
January 2023
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Graft Versus Host Disease Treatment market will undergo...
Catalog:
Arsta
April 2022
Price: USD 3,360.00
FGFR3, also known as CD333, Is a member of the fibroblast growth factor receptor (FGFR) family, with its amino acid sequence being highly conserved...
Catalog:
LPI
February 2023
Price: USD 3,660.00
